drugset / Trial / NCT07012902

Relationship Between Remimazolam and Etomidate in Induction of General Anesthesia

NCT07012902

Phase 0 Not yet recruiting 125 enrolled Second Hospital of Shanxi Medical University
RandomizedSequentialOpen-labelOther

Summary

In modern anesthesia practice, anesthesiologists often need to choose a combination of multiple drugs according to the specific conditions and surgical needs of patients, which can not only achieve more fine anesthesia management, but also improve perioperative safety and patient comfort. In clinical practice, anesthesiologists will use etomidate combined with a small dose of remimazolam for anesthesia induction to obtain more stable hemodynamics, prevent intraoperative awareness, and relieve anxiety.However, what is the best dose ratio of etomidate combined with remimazolam, the current literature does not give clear indicators.

Timeline

Start
2025-06-12
Primary completion
2025-06-19
Completion
2025-07-19

Drugs

EvaluationDrugModalityDoseRoute
Subject Etomidate Small molecule 0.12 mg/kg Intravenous
Subject Etomidate Small molecule Intravenous
Subject Remimazolam Small molecule 0.2 mg/kg Intravenous
Subject Remimazolam Small molecule Intravenous

Indications

No indication recorded.